Mobivity (MFON) 10-Q 16 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Incorporation, State Country Code	NV
Tax Identification Number (TIN)	26-3439095
Entity Address, Address Line One	3133 West Frye Road
Entity Address, Address Line Two	# 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	877
Local Phone Number	282-7660
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		58,598,885
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0001447380
Amendment Flag	false
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 1,455,147	$ 735,424
Accounts receivable, net of allowance for doubtful accounts of $53,514 and $56,340, respectively	491,004	578,303
Other current assets	333,207	227,458
Total current assets	2,279,358	1,541,185
Goodwill	411,183	411,183
Right to use lease assets	1,132,317	1,187,537
Intangible assets, net	1,015,690	1,124,720
Other assets	157,366	173,325
TOTAL ASSETS	4,995,914	4,437,950
Current liabilities
Accounts payable	3,503,464	3,823,909
Accrued interest	305,364	172,239
Accrued and deferred personnel compensation	292,430	495,533
Deferred revenue and customer deposits	173,379	377,170
Related party notes payable	1,479,167	819,531
Notes payable, net - current maturities	41,577	69,052
Operating lease liability	237,761	229,240
Other current liabilities		9,071
Total current liabilities	6,033,142	5,995,745
Non-current liabilities
Related party notes payable, net - long term	1,857,079	2,498,711
Notes payable, net - long term	61,794	39,086
Operating lease liability	1,127,670	1,188,589
Total non-current liabilities	3,046,543	3,726,386
Total liabilities	9,079,685	9,722,131
Stockholders' equity (deficit)
Common stock, $0.001 par value; 100,000,000 shares authorized; 58,598,885 and 55,410,695, shares issued and outstanding	58,599	55,411
Equity payable	100,862	100,862
Additional paid-in capital	105,590,137	102,446,921
Accumulated other comprehensive income (loss)	(64,983)	(52,088)
Accumulated deficit	(109,768,386)	(107,835,287)
Total stockholders' equity (deficit)	(4,083,771)	(5,284,181)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 4,995,914	$ 4,437,950

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Condensed Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 53,514	$ 56,340
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	58,598,885	55,410,695
Common stock, shares outstanding	58,598,885	55,410,695

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues
Revenues	$ 2,029,569	$ 2,457,590
Cost of revenues	1,174,948	1,041,795
Gross profit	854,621	1,415,795
Operating expenses
General and administrative	1,207,176	1,289,370
Sales and marketing	597,501	896,750
Engineering, research, and development	702,223	723,950
Impairment of intangible asset		8,286
Depreciation and amortization	124,312	158,227
Total operating expenses	2,631,212	3,076,583
Loss from operations	(1,776,591)	(1,660,788)
Other income/(expense)
Interest income		5
Interest expense	(159,827)	(32,516)
Foreign currency gain (loss)	3,319	(474)
Total other income/(expense)	(156,508)	(32,985)
Loss before income taxes	(1,933,099)	(1,693,773)
Income tax expense
Net loss:	(1,933,099)	(1,693,773)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments	(12,895)	(9,678)
Comprehensive loss	$ (1,945,994)	$ (1,703,451)
Net loss per share:
Basic and Diluted	$ (0.03)	$ (0.03)
Weighted average number of shares:
Basic And Diluted	57,233,309	55,410,695

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 55,411	$ 100,862	$ 101,186,889	$ (23,446)	$ (99,575,503)	$ 1,744,213
Beginning balance, shares at Dec. 31, 2020	55,410,695
Stock based compensation			228,623			228,623
Foreign currency translation adjustment				(9,678)		(9,678)
Net loss					(1,693,773)	(1,693,773)
Ending balance, value at Mar. 31, 2021	$ 55,411	100,862	101,415,512	(33,124)	(101,269,276)	269,385
Ending balance, shares at Mar. 31, 2021	55,410,695
Beginning balance, value at Dec. 31, 2020	$ 55,411	100,862	101,186,889	(23,446)	(99,575,503)	1,744,213
Beginning balance, shares at Dec. 31, 2020	55,410,695
Net loss						(8,300,000)
Ending balance, value at Dec. 31, 2021	$ 55,411	100,862	102,446,921	(52,088)	(107,835,287)	(5,284,181)
Ending balance, shares at Dec. 31, 2021	55,410,695
Issuance of common stock for warrant	$ 3,188		2,547,365			2,550,553
Issuance of common stock for warrant, Shares	3,188,190
Fair value of options issued with related party			6,201			6,201
Stock based compensation			589,650			589,650
Foreign currency translation adjustment				(12,895)		(12,895)
Net loss					(1,933,099)	(1,933,099)
Ending balance, value at Mar. 31, 2022	$ 58,599	$ 100,862	$ 105,590,137	$ (64,983)	$ (109,768,386)	$ (4,083,771)
Ending balance, shares at Mar. 31, 2022	58,598,885

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
OPERATING ACTIVITIES
Net loss	$ (1,933,099)	$ (1,693,773)	$ (8,300,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	(10,705)	11,297
Stock-based compensation	589,650	228,623
Intangible asset impairment		8,286
Goodwill impairment			85,169
Depreciation and amortization expense	124,312	141,591
Amortization of Debt Discount	24,205
Increase (decrease) in cash resulting from changes in:
Accounts receivable	98,004	(1,071,359)
Other current assets	(105,749)	(70,901)
Operating lease assets/liabilities	2,822	16,636
Contracts receivable, long-term		235,976
Other assets		(108,652)
Accounts payable	(320,445)	308,399
Accrued interest	133,125	(15,775)
Accrued and deferred personnel compensation	(203,103)	248,828
Other liabilities - non-current	(9,071)	(138,589)
Other liabilities - current		(36,130)
Deferred revenue and customer deposits	(203,791)	33,584
Net cash used in operating activities	(1,813,845)	(1,901,959)	4,500,000
INVESTING ACTIVITIES
Purchases of equipment		(75,852)
Capitalized software development costs		(50,588)
Net cash used in investing activities		(126,440)
FINANCING ACTIVITIES
Payments on notes payable	(6,354)	(141,058)
Payments on related party notes payable		(80,000)
Proceeds from conversion of common stock warrants	2,550,553
Net cash provided by (used in) financing activities	2,544,199	(221,058)
Effect of foreign currency translation on cash flow	(10,631)	(6,155)
Net change in cash	719,723	(2,255,612)
Cash at beginning of period	735,424	3,282,820	3,282,820
Cash at end of period	1,455,147	1,027,208	$ 735,424
Cash paid during period for:
Interest		29,541
Non Cash investing and financing activities:
Fair Value of Options issued with related party debt	$ 6,201
Fixed Assets Contributed by Lessor		110,000
Initial ROU asset and lease liability		$ 1,458,527

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Nature of Operations and Basis of Presentation [Abstract]
Nature of Operations and Basis of Presentation	1. Nature of Operations and Basis of Presentation Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable and intellectual property. We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 30, 2022. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of March 31, 2022, and for the three months ended March 31, 2022 and 2021. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the operating results for the full year ending December 31 , 2022.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates. Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss. Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of March 31, 2022, and December 31, 2021, we recorded an allowance for doubtful accounts of $ 53,514 and $ 56,340 , respectively. Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2021. As a result of these tests, we had a total impairment charges of $ 85,169 . Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year to twenty years . No significant residual value is estimated for intangible assets. The Company’s evaluation of its long-lived assets completed resulted in $ 0 and $ 8,286 of intangible impairment expense during the quarters ended March 31, 2022 and March 31, 2021. Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer.The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $ 0 for the quarter ended March 31, 2022 and $ 0 for the year ended December 31, 2021.. Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”) . Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income. Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps:  identification of the contract, or contracts, with a customer;  identification of the performance obligations in the contract;  identification of the transaction price;  allocation of the transaction price to the performance obligations in the contract; and  recognition of revenue when, or as, we satisfy a performance obligation. During the three months ended March 31, 2022 and 2021, two customers accounted for 53 % and 64 % of our revenues, respectively. Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the three months ended March 31 , 2022 and 2021, the comprehensive loss was $ 1,945,994 , and $ 1,703,451 respectively. Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $ 163,734 and $ 188,343 for the three months ended March 31, 2022 and 2021, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $ 10,000 and $ 0 of expense related to those activities for the three months ended March 31, 2022 and 2021, respectively. Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained. Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three months ended March 31, 2022 and 2021, we had securities outstanding which could potentially dilute basic earnings per share in the future. Those were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive. Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”). ASU No. 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The company adopted January 1, 2022.

Going Concern

Going Concern	3 Months Ended
	Mar. 31, 2022
Going Concern [Abstract]
Going Concern	3. Going Concern We have $ 1,455,147 of cash as of March 31, 2022. We had a net loss of $ 1.9 million for the quarter then ended, and we used $ 1.8 million of cash in our operating activities during the quarter ended March 31, 2022. In 2021, we had a net loss of $ 8.3 million and used $ 4.5 million of cash in our operating expenses. We raised $ 2,550,553 in cash exercise of warrants in February 2022. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will not be sufficient to fund our 12-month plan of operations, there can be no assurance that we will not require significant additional capital within 12 months. As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $ 109,768,386 as of March 31, 2022. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with the proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

Goodwill and Purchased Intangib

Goodwill and Purchased Intangibles	3 Months Ended
	Mar. 31, 2022
Goodwill and Purchased Intangibles [Abstract]
Goodwill and Purchased Intangibles	4. Goodwill and Purchased Intangibles Goodwill The carrying value of goodwill at March 31, 2022 and December 31, 2021 was $ 411,183 . The following table presents details of our purchased intangible assets as of March 31, 2022 and December 31, 2021: Intangible assets Balance at December 31, 2021 Additions Impairments Amortization Fx and Other Balance at March 31, 2022 Patents and trademarks $ 57,595 $ — $ — $ ( 4,376 ) $ 3,147 $ 56,366 Customer and merchant relationships 545,533 — — ( 24,213 ) — 521,320 Trade name 32,393 — — ( 2,259 ) — 30,134 Acquired technology 112,191 — — ( 4,075 ) — 108,116 Non-compete agreements 29,212 — — ( 3,965 ) — 25,247 $ 776,924 $ — $ — $ ( 38,888 ) $ 3,147 $ 741,183 The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year to twenty years . Amortization expense for intangible assets was $ 38,888 and $ 36,004 for the three months ended March 31, 202 and 2021, respectively. The estimated future amortization expense of our intangible assets as of March 31, 2022 is as follows: Year ending December 31, Amount 2022 $ 111,085 2023 145,606 2024 109,009 2025 101,261 2026 101,261 Thereafter 172,961 Total $ 741,183

Software Development Costs

Software Development Costs	3 Months Ended
	Mar. 31, 2022
Software Development Costs [Abstract]
Software Development Costs	4. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities The following table presents details of our software development costs as of March 31, 2022 and December 31, 2021: Balance at December 31, 2021 Additions Amortization Balance at March 31, 2022 Software Development Costs $ 347,796 $ $ ( 73,289 ) $ 274,507 $ 347,796 $ $ ( 73,289 ) $ 274,507 Software development costs are being amortized on a straight-line basis over their estimated useful life of two years . Amortization expense for software development costs was $ 73,289 and $ 99,209 for the three months ended March 31, 2022 and 2021, respectively. The estimated future amortization expense of software development costs as of March 31, 2022 is as follows: Year ending December 31, Amount 2022 $ 182,021 2023 92,161 2024 325 2025 — 2026 — Thereafter — Total $ 274,507

Operating Lease Assets

Operating Lease Assets	3 Months Ended
	Mar. 31, 2022
Operating Lease Assets [Abstract]
Operating Lease Assets	5. Operating Lease Assets The Company entered into a lease agreement on February 1, 2021 for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $ 25,953 to $ 28,733 . The first twelve months of the lease includes a 50 % abatement period and a deposit for $ 110,000 was required. The lessor contributed $ 110,000 towards the purchase of office furniture as part of the lease agreement. As of March 31, 2022, we have an operating lease asset balance of $ 1,132,317 and an operating lease liability balance of $ 1,365,431 recorded in accordance with ASC 842. The following are additional details related to leases recorded on our balance sheet as of March 31, 2022: Leases Classification Balance at March 31, 2022 Assets Current Operating lease assets Operating lease assets $ Noncurrent Operating lease assets Noncurrent operating lease assets $ 1,132,317 Total lease assets $ 1,132,317 Liabilities Current Operating lease liabilities Operating lease liabilities $ 237,761 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 1,127,670 Total lease liabilities $ 1,365,431 The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term and weighted average discount rate: Year ending December 31, Amount 2022 $ 241,949 2023 324,221 2024 330,894 2025 337,568 2026 344,241 Thereafter 28,733 Total future lease payments 1,607,606 Less: imputed interest ( 242,175 ) Total $ 1,365,431 Weighted Average Remaining Lease Term (years) Operating leases 5.6 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Expe

Notes Payable and Interest Expense	3 Months Ended
	Mar. 31, 2022
Notes Payable and Interest Expense [Abstract]
Notes Payable and Interest Expense	6. Notes Payable and Interest Expense The following table presents details of our notes payable as of March 31, 2022 and December 31, 2021: Facility Maturity Interest Rate Balance at March 31, 2022 Balance at Dcember 31, 2021 ACOA Note February 1, 2024 — 71,389 76,642 TD Bank December 31, 2022 — 31,982 31,496 Related Party Note various 15 % 3,336,246 3,318,242 Total Debt 3,439,617 3,426,380 Less current portion 1,520,744 888,583 Long-term debt, net of current portion $ 1,918,873 $ 2,537,797 ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014 with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement the note will mature, and the commitments will terminate on February 1, 2024 . The monthly principal payment amount of $ 3,000 CAD increased to $ 3,500 CAD beginning on November 1, 2019, $ 4,000 CAD on August 1, 2021, $ 4,500 CAD on August 1, 2022, and $ 2,215 CAD during the remaining term of the agreement. Payments from April-December of 2020 were voluntarily deferred by ACOA due to COVID-19. During the three months ended March 31, 2022 we repaid $ 6,554 USD of principal. TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $ 40,000 CAD, which is due and payable on December 31, 2022 . This note bears interest on the unpaid balance at the rate of zero percent ( 0 %) per annum during the initial term. Under this note no interest or principal payments are due until January 1, 2023. Under the conditions of the loan, twenty-five percent ( 25 %) of the loan will be forgiven if seventy-five percent ( 75 %) is repaid prior to the initial term date. Related Party Notes On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $ 200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2 %) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $ 500,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2 %) pre-payment penalty. On December 31, 2020 $ 1,200,000 of these Notes and the accrued interest of $ 192,208 was settled into equity and we recorded a loss on settlement of debt of $ 668,260 for the year ended December 31, 2020. In summary, as of December 31, 2020, we have a principal balance of $ 580,000 and accrued interest of $ 42,492 outstanding. On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $ 3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $ 200,000 was paid toward the principal balance of the note. As of December 31, 2021, the company has drawn a total of $ 3,478,125 including cash in the amount of $ 3,206,250 and $ 271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $ 149,040 . The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024 . This loan bears interest on unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $ 1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent ( 20 %) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three year period at an exercise price equal to the VWAP. During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $ 262,758 using the Black-Scholes option valuation model as of December 31, 2021. On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $ 271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum and the principal and accrued interest is due and payable no later than July 1, 2023 . We may prepay any of the Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. During the twelve month period ending December 31, 2021, the Company issued warrants to purchase an aggregate of 600,570 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is $ 286,296 using the Black-Scholes option valuation model as of March 31, 2022. During the three month period ending March 31, 2021, the Company issued warrants to purchase an aggregate of 20,339 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. The estimated aggregate fair value of the warrants issued is 6,201 using the Black-Scholes option valuation model as of March 31, 2022 Interest Expense Interest expense was $ 159,827 and $ 32,516 during the three months ended March 31, 2022 and 2021, respectively.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity [Abstract]
Stockholders' Equity	7. Stockholders’ Equity Common Stock 2021 During the year ended December 31, 2021, the Company did not issue any shares but, recorded stock-based compensation expense of $ 260,005 related to restricted stock units for members of our board of directors. The company recorded stock-based compensation expense of $ 187,501 related to restricted stock units for employee compensation. 2022 On February 9, 2022 seventeen warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $ 0.80 per share, resulting in additional capital of $ 2,550,553 . As an inducement for the holder’s exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $ 1.50 per share over a three year period expiring in February 2025 and recorded additional stock-based expense of $ 382,048 During the quarter ended March 31, 2022 the Company recorded stock-based compensation expense of $ 65,002 related to restricted stock units for members of our board of directors. The company recorded stock-based compensation expense of $ 207,603 related to stock units for employee compensation. As of March 31, 2021 we had an equity payable balance of $ 100,862 . Stock-based Plans Stock Option Activity The following table summarizes stock option activity for the three months ended March 31, 2022. Options Outstanding at December 31, 2020 6,007,552 Granted 637,500 Exercised — Forfeit/canceled ( 272,029 ) Expired ( 126,557 ) Outstanding at December 31, 2021 6,246,466 Granted 150,000 Exercised — Forfeit/canceled ( 65,000 ) Expired ( 10,250 ) Outstanding at March 31, 2022 6,321,216 The weighted average exercise price of stock options granted during the period was $ 0.83 and the related weighted average grant date fair value was $ 0.54 per share. 2021 On March 26, 2021, the Company granted five employees a total of 67,500 options to purchase shares of the Company common stock at the closing price as of March 26, 2021 of $ 1.80 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 26, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.97 % and an option fair value of $ 1.16 was $ 78,492 . On May 2, 2021, the Company granted one employee a total of 20,000 options to purchase shares of the Company common stock at the closing price as of May 2, 2021, of $ 1.48 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until May 2, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.79 % and an option fair value of $ 0.93 was $ 18,628 . On August 11, 2021, the Company granted one employee a total of 5,000 options to purchase shares of the Company common stock at the closing price as of August 11, 2021, of $ 1.75 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until August 11, 2031. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.29 % and an option fair value of $ 1.12 was $ 5,606 . 2022 On March 29, 2022, the Company granted one employee 150,000 options to purchase shares of the Company common stock at the closing price as of March 29, 2022, of $ 0.8289 per share. The option shares will vest 25 % on the first anniversary of the grant, then equally in 36 monthly installments thereafter and are exercisable until March 29, 2032. The total estimated value using the Black-Scholes Model, based on a volatility rate of 72.33 % and an option fair value of $ 0.54 was $ 81,035 . Stock-Based Compensation Expense from Stock Options and Warrants The impact on our results of operations of recording stock-based compensation expense for the three months ended March 31, 2022 and 2021 were as follows: Three Months Ended March 31, 2022 2021 General and administrative $ 128,246 $ 84,130 Sales and marketing 12,867 32,745 Engineering, research, and development 66,490 43,052 $ 207,603 $ 159,927 Valuation Assumptions The fair value of each stock option award was calculated on the date of grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the three months ended March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 Risk-free interest rate 2.47 % 1.01 % Expected life (years) 6.00 6.00 Expected dividend yield — % — % Expected volatility 72.33 % 73.97 % The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2022 and 2021 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2021 and for the three months ended March 31, 2022: Shares Outstanding at December 31, 2020 1,436,728 Awarded 654,663 Released — Canceled/forfeited/expired ( 406,250 ) Outstanding at December 31, 2021 1,685,141 Awarded 78,420 Released — Canceled/forfeited/expired — Outstanding at March 31, 2022 1,763,561 Expected to vest at March 31, 2022 1,763,561 Vested at March 31, 2022 1,763,561 Unvested at March 31, 2022 — Unrecognized expense at March 31, 2022 $ — 2021 On March 26, 2021, the Company issued to four independent directors a total of 36,112 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the first quarter of 2021. The units were valued at $ 65,002 or $ 1.80 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) March 26, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On March 26, 2021, the Company granted to one employee 1,000,000 restricted shares of the Company’s Common Stock at the closing price as of March 26, 2021 of $ 1.80 per share. The restricted stock will vest as follows (a) 50 % of the restricted shares will vest ratably over forty eight months ; (b) 15 % of the restricted shares will vest upon the Company achieving $ 25,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter; (c) the final 35 % of the restricted shares will vest upon the Company achieving $ 50,000,000 in annualized recurring revenues as reported by totaling all contracted revenues for the trailing twelve months following the end of a reporting quarter. Vesting is dependent on the employee’s continued employment with the Company. All of the 1,000,000 restricted shares will include a single trigger accelerated vesting should the Company undergo a change of control after August 1, 2021. If the Company undergoes a change of control prior to August 1, 2021, 300,000 of the restricted shares would be eligible for single trigger accelerated vesting. On May 12, 2021, the Company issued to four independent directors a total of 38,924 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the second quarter of 2021. The units were valued at $ 65,002 or $ 1.67 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) May 2, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On August 11, 2021, the Company issued to four independent directors a total of 37,143 restricted stock units. These restricted stock units were issued for the $ 65,000 of board compensation earned for the third quarter of 2021. The units were valued at $ 65,000 or $ 1.75 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) , August 11, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. On December 15, 2021, the Company granted four independent directors a total of 42,484 restricted stock units. The units were valued at $ 65,000 or $ 1.53 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. 2022 On March 29, 2022 the company grated granted four independent directors a total of 78,420 restricted stock units. The units were valued at $ 65,002 or $ 0.829 per share, based on the closing stock price on the date of grant. All units vested immediately. The shares of Common Stock associated with the Restricted Stock Unit evidenced by this Agreement will be issued to the director upon the earliest to occur of (A) December 15, 2024, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company. In the three months ended March 31, 2022, the company recorded $ 65,002 in restricted stock units as board compensation. Stock Based Compensation from Restricted Stock The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three months ended March 31, 2022 and 2021 was as follows: Three Months Ended March 31, 2022 2021 General and administrative $ 65,002 $ 65,002 Sales and marketing $ — $ 3,694 $ 65,002 $ 68,696 As of March 31, 2022, there was no unearned restricted stock unit compensation. Warrants The following table summarizes investor warrant as of March 31, 2022 and the years ended for the year ended December 31, 2021 and, 2020: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired ( 25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 3,208,529 $ — — Exercised ( 3,188,190 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at March 31, 2022 3,267,029 $ 0.83 2.85 2020 On March 2, 2020 one warrant holder exercised their common stock purchase warrant for 234,500 shares at the exercise price of $ 1.00 per share, resulting in additional capital of $ 234,500 . In December 2020, warrant holders exercised warrants to purchase common stock at $ 1.25 per share. At the commencement of the December warrant exercise, there were warrants outstanding that entitled their holders to purchase 2,691,459 shares of our common stock at exercise prices of $ 1.25 per share. Pursuant to the offer, warrant holders exercised warrants to purchase 2,666,459 shares of our common stock, resulting in additional capital of $ 3,333,074 . As part of the exercise, 2,666,459 new warrants were issued to purchase common stock at $ 2.00 per share within three years. 2021 On June 30, 2021, the company issued warrants to purchase an aggregate of 227,994 shares of its common stock at an exercise price of $ 1.67 per share for 119,760 inducement warrants and VWAP for 108,234 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $ 119,103 using the Black-Scholes option valuation model. On August 11, 2021 the company issued warrants of in connection with loan by related party VWAP for 10,072 additional warrants in connection with the issuance of a loan by a related party. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. The estimated aggregate fair value of the warrants issued is $ 5,285 using the Black-Scholes option valuation model As of September 30, 2021, we have outstanding warrants to purchase 2,666,459 shares of common stock at $ 2.06 per share. These warrants expire in 2023. We also have outstanding warrants to purchase 238,066 shares of common stock at stated price per share in connection with the issuance of a loan with a related party. These warrants expire in 2024. 2022 On February 9, 2022 seventeen warrant holders exercised their common stock purchase warrant for 3,188,190 shares at the exercise price of $ 0.80 per share, resulting in additional capital of $ 2,550,553 . As an inducement for the holder’s exercise of the warrants, we issued the holders 3,188,190 new warrants to purchase common stock at $ 1.50 per share over a three year period expiring in February 2025. During the quarter ended March 31, 2021 he company recorded $ 382,048 of stock-based expense related to warrants issued during the warrant conversion offer on February 9, 2022.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	8. Fair Value Measurements Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value. The following table presents assets that are measured and recognized at fair value as of March 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,015,690 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2021 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ —

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies Litigation As of the date of this report, there are no pending legal proceedings to which we or our properties are subject, except for routine litigation incurred in the normal course of business. Operating Lease As described in Note 5, the Company has a lease agreement for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $ 25,953 to $ 28,733 . The first twelve months of the lease includes a 50 % abatement period. As of March 31, 2022, we have an operating lease asset balance for this lease of $ 1,129,679 and an operating lease liability balance for this lease of $ 1,362,079 recorded in accordance with ASC 842 The Company also has a lease through April 2022 for 3,248 square feet of office space located in Halifax, Nova Scotia, at a monthly rental expense of $ 2,665 to $ 3,371 per month, excluding common area maintenance charges. As of March 31, 2022, we have an operating lease asset balance for this lease of $ 2,638 and an operating lease liability balance for this lease of $ 3,352 recorded in accordance with ASC 842.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	10. Related Party Transactions Unsecured Promissory Note Investments 2020 During February 2018, we conducted a private placement of Unsecured Promissory Notes (individually, a “ Note ” and collectively, the “ Notes ”) in the aggregate principal amount of $ 1,080,000 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum and the principal and accrued interest is due and payable no later than December 1, 2020. We may prepay any of the Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. On February 26, 2020, we issued an unsecured Note in the principle aggregate amount of $ 200,000 , which becomes due two years after the date of issuance. This Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, subject to a two percent ( 2 %) pre-payment penalty. On November 18, 2020, we issued two additional unsecured Notes in the principle aggregate amount of $ 500,000 , which becomes due two years after the date of issuance. These Notes bear interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay these Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. On December 31, 2020 $ 1,200,000 of these Notes and the accrued interest of $ 192,208 was settled into equity. We recorded a loss on settlement of debt of $ 668,260 for the year ended December 31, 2020. 2021 On July 1, 2021 we entered into an Unsecured Promissory Notes (individually, a “Note” and collectively, the “Notes”) in the aggregate principal amount of $ 271,875 to certain investors, officers and directors of the Company. Each Note bears interest on the unpaid balance at the rate of fifteen percent ( 15 %) per annum and the principal and accrued interest is due and payable no later than July 1, 2023 . We may prepay any of the Notes without notice, subject to a two percent ( 2 %) pre-payment penalty. The Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this Credit Agreement. Secured Promissory Note Investments 2021 On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with one of the Company’s directors. The Company can borrow up to $ 3,500,000 under this Credit Agreement. On November 19, 2021, a payment of $ 200,000 was paid toward the principal balance of the note. On November 19, 2021, a payment of $ 200,000 was paid toward the principal balance of the note. As of March 31, 2022, the company has drawn a total of $ 3,478,125 including cash in the amount of $ 3,206,250 and $ 271,875 of principal and accrued interest under the above-described Note that was rolled into the Credit Facility. As of December 31, 2021, we have accrued interest of $ 149,040 . The loan is secured by all our tangible and intangible assets including intellectual property. We will repay the principal amount plus accrued interest in 24 equal monthly installments commencing on June 30, 2022 and ending on June 30, 2024 . This loan bears interest on unpaid balance at the rate of fifteen percent ( 15 %) per annum. The Company may prepay this Note without notice, penalty or charge. In consideration of the lender’s agreement to provide the facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $ 1.67 per share in connection with the issuance of funds under this Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the lender additional warrants entitling the lender to purchase a number of shares of the Company common stock equal to twenty percent ( 20 %) of the amount of the advances made divided by the volume weighted average price over the 30 trading days preceding the advance (VWAP). Each warrant will be exercisable over a three year period at an exercise price equal to the VWAP.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events On April 30, 2022 our lease on the office located in Halifax, Nova Scotia expired. We did not renew the lease.

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Policy)	3 Months Ended
	Mar. 31, 2022
Nature of Operations and Basis of Presentation [Abstract]
Nature of Operations	Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable and intellectual property. We generate revenue by charging the resellers, brands and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.
Basis of Accounting	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 30, 2022.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policy)	3 Months Ended
	Mar. 31, 2022
Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates used are those related to stock-based compensation, asset impairments, the valuation and useful lives of depreciable tangible and certain intangible assets, the fair value of common stock used in acquisitions of businesses, the fair value of assets and liabilities acquired in acquisitions of businesses, the fair value of options issued with related party debt, and the valuation allowance of deferred tax assets. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications had no effect on previously reported net loss.
Acquisitions	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash and Cash Equivalents	Cash and Cash Equivalents We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of March 31, 2022, and December 31, 2021, we recorded an allowance for doubtful accounts of $ 53,514 and $ 56,340 , respectively.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than it’s carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2021. As a result of these tests, we had a total impairment charges of $ 85,169 . Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year to twenty years . No significant residual value is estimated for intangible assets. The Company’s evaluation of its long-lived assets completed resulted in $ 0 and $ 8,286 of intangible impairment expense during the quarters ended March 31, 2022 and March 31, 2021.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the FASB guidance for the costs of computer software to be sold, leased, or otherwise marketed (“ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. Technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are cancelled or abandoned are charged to product development expense in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four month period. The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer.The Company’s evaluation of its capitalized software development asset resulted in impairment charges of $ 0 for the quarter ended March 31, 2022 and $ 0 for the year ended December 31, 2021..
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of Accounting Standards Codification subtopic 830-10, Foreign Currency Matters (“ASC 830-10”) . Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Accounting Standards Codification 606 (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps:  identification of the contract, or contracts, with a customer;  identification of the performance obligations in the contract;  identification of the transaction price;  allocation of the transaction price to the performance obligations in the contract; and  recognition of revenue when, or as, we satisfy a performance obligation. During the three months ended March 31, 2022 and 2021, two customers accounted for 53 % and 64 % of our revenues, respectively.
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at comprehensive loss. For the three months ended March 31 , 2022 and 2021, the comprehensive loss was $ 1,945,994 , and $ 1,703,451 respectively.
Stock-based Compensation	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of E-commerce advertisements, sales enablement, content creation, and other direct costs. Advertising expense was $ 163,734 and $ 188,343 for the three months ended March 31, 2022 and 2021, respectively. We also include the cost of attending trade shows under marketing expense. We recorded $ 10,000 and $ 0 of expense related to those activities for the three months ended March 31, 2022 and 2021, respectively.
Income Taxes	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three months ended March 31, 2022 and 2021, we had securities outstanding which could potentially dilute basic earnings per share in the future. Those were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following are a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity's Own Equity (“ASU 2020-06” or the “ASU”). ASU No. 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The company adopted January 1, 2022.

Goodwill and Purchased Intang_2

Goodwill and Purchased Intangibles (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Purchased Intangibles [Abstract]
Intangible Assets	Balance at December 31, 2021 Additions Impairments Amortization Fx and Other Balance at March 31, 2022 Patents and trademarks $ 57,595 $ — $ — $ ( 4,376 ) $ 3,147 $ 56,366 Customer and merchant relationships 545,533 — — ( 24,213 ) — 521,320 Trade name 32,393 — — ( 2,259 ) — 30,134 Acquired technology 112,191 — — ( 4,075 ) — 108,116 Non-compete agreements 29,212 — — ( 3,965 ) — 25,247 $ 776,924 $ — $ — $ ( 38,888 ) $ 3,147 $ 741,183
Future Amortization Intangible Assets	Year ending December 31, Amount 2022 $ 111,085 2023 145,606 2024 109,009 2025 101,261 2026 101,261 Thereafter 172,961 Total $ 741,183

Software Development Costs (Tab

Software Development Costs (Tables)	3 Months Ended
	Mar. 31, 2022
Software Development Costs [Abstract]
Software Development Costs	Balance at December 31, 2021 Additions Amortization Balance at March 31, 2022 Software Development Costs $ 347,796 $ $ ( 73,289 ) $ 274,507 $ 347,796 $ $ ( 73,289 ) $ 274,507
Future Amortization of Software	Year ending December 31, Amount 2022 $ 182,021 2023 92,161 2024 325 2025 — 2026 — Thereafter — Total $ 274,507

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Operating Lease Assets [Abstract]
Additional Details Related to Leases on Balance Sheet	Leases Classification Balance at March 31, 2022 Assets Current Operating lease assets Operating lease assets $ Noncurrent Operating lease assets Noncurrent operating lease assets $ 1,132,317 Total lease assets $ 1,132,317 Liabilities Current Operating lease liabilities Operating lease liabilities $ 237,761 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 1,127,670 Total lease liabilities $ 1,365,431
Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates	Year ending December 31, Amount 2022 $ 241,949 2023 324,221 2024 330,894 2025 337,568 2026 344,241 Thereafter 28,733 Total future lease payments 1,607,606 Less: imputed interest ( 242,175 ) Total $ 1,365,431 Weighted Average Remaining Lease Term (years) Operating leases 5.6 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	3 Months Ended
	Mar. 31, 2022
Notes Payable and Interest Expense [Abstract]
Schedule of Notes Payable	Facility Maturity Interest Rate Balance at March 31, 2022 Balance at Dcember 31, 2021 ACOA Note February 1, 2024 — 71,389 76,642 TD Bank December 31, 2022 — 31,982 31,496 Related Party Note various 15 % 3,336,246 3,318,242 Total Debt 3,439,617 3,426,380 Less current portion 1,520,744 888,583 Long-term debt, net of current portion $ 1,918,873 $ 2,537,797

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Option Activity	Options Outstanding at December 31, 2020 6,007,552 Granted 637,500 Exercised — Forfeit/canceled ( 272,029 ) Expired ( 126,557 ) Outstanding at December 31, 2021 6,246,466 Granted 150,000 Exercised — Forfeit/canceled ( 65,000 ) Expired ( 10,250 ) Outstanding at March 31, 2022 6,321,216
Valuation Assumptions	Three Months Ended March 31, 2022 2021 Risk-free interest rate 2.47 % 1.01 % Expected life (years) 6.00 6.00 Expected dividend yield — % — % Expected volatility 72.33 % 73.97 %
Restricted Stock Unit Activity	Shares Outstanding at December 31, 2020 1,436,728 Awarded 654,663 Released — Canceled/forfeited/expired ( 406,250 ) Outstanding at December 31, 2021 1,685,141 Awarded 78,420 Released — Canceled/forfeited/expired — Outstanding at March 31, 2022 1,763,561 Expected to vest at March 31, 2022 1,763,561 Vested at March 31, 2022 1,763,561 Unvested at March 31, 2022 — Unrecognized expense at March 31, 2022 $ —
Summary of Investor Warrant Activity	Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2020 2,691,459 $ 1.99 2.94 Granted 580,231 $ — — Exercised — $ — — Canceled/forfeited/expired ( 25,000 ) $ — — Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 3,208,529 $ — — Exercised ( 3,188,190 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at March 31, 2022 3,267,029 $ 0.83 2.85
Stock Options and Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	Three Months Ended March 31, 2022 2021 General and administrative $ 128,246 $ 84,130 Sales and marketing 12,867 32,745 Engineering, research, and development 66,490 43,052 $ 207,603 $ 159,927
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-Based Compensation Expense	Three Months Ended March 31, 2022 2021 General and administrative $ 65,002 $ 65,002 Sales and marketing $ — $ 3,694 $ 65,002 $ 68,696

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Measurements [Abstract]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents assets that are measured and recognized at fair value as of March 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,015,690 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2021 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains (Losses) Goodwill (non-recurring) $ — $ — $ 411,183 $ — Intangibles, net (non-recurring) $ — $ — $ 1,124,720 $ —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Narrative) (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022USD ($)customer	Mar. 31, 2021USD ($)customer	Dec. 31, 2021USD ($)
Product Information [Line Items]
Accounts receivable, allowance for doubtful accounts	$ 53,514		$ 56,340
Impairment charges on evaluation of goodwill			85,169
Impairment charges on long-lived assets	0	$ 8,286
Advertising expense	163,734	188,343
Marketing expense	10,000	0
Comprehensive loss	$ (1,945,994)	$ (1,703,451)
Software Development Costs [Member]
Product Information [Line Items]
Estimated useful lives	2 years
Intangible asset impairment	$ 0		$ 0
Sales Revenue Net [Member]
Product Information [Line Items]
Number of significant customers | customer	2	2
Sales Revenue Net [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Customer concentration risk	53.00%	64.00%
Minimum [Member]
Product Information [Line Items]
Estimated useful lives	1 year
Maximum [Member]
Product Information [Line Items]
Estimated useful lives	20 years

Going Concern (Narrative) (Deta

Going Concern (Narrative) (Details) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 28, 2022	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Going Concern [Abstract]
Cash		$ 1,455,147		$ 735,424
Net loss		(1,933,099)	$ (1,693,773)	(8,300,000)
Net cash used in operating activities		(1,813,845)	$ (1,901,959)	4,500,000
Proceeds from warrant exercises	$ 2,550,553
Accumulated deficit		$ (109,768,386)		$ (107,835,287)

Goodwill and Purchased Intang_3

Goodwill and Purchased Intangibles (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 411,183		$ 411,183
Amortization expense	$ 38,888	$ 36,004
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	1 year
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	20 years
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 4,376

Goodwill and Purchased Intang_4

Goodwill and Purchased Intangibles (Intangible Assets) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	$ 776,924
Amortization	(38,888)	$ (36,004)
Fx and Other	3,147
Balance at end of period	741,183
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	57,595
Amortization	(4,376)
Fx and Other	3,147
Balance at end of period	56,366
Customer and Merchant Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	545,533
Amortization	(24,213)
Balance at end of period	521,320
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	32,393
Amortization	(2,259)
Balance at end of period	30,134
Acquired technology [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	112,191
Amortization	(4,075)
Balance at end of period	108,116
Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	29,212
Amortization	(3,965)
Balance at end of period	$ 25,247

Goodwill and Purchased Intang_5

Goodwill and Purchased Intangibles (Future Amortization Intangible Assets) (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total	$ 741,183	$ 776,924
Intangible Assets Excluding Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2022	111,085
2023	145,606
2024	109,009
2025	101,261
2026	101,261
Thereafter	172,961
Total	$ 741,183

Software Development Costs (Nar

Software Development Costs (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization of computer software	$ 73,289
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives	2 years
Amortization of computer software	$ 73,289	$ 99,209

Software Development Costs (Sof

Software Development Costs (Software Development Costs) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	$ 347,796
Amortization	(73,289)
Balance at end of period	274,507
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Balance at beginning of period	347,796
Amortization	(73,289)	$ (99,209)
Balance at end of period	$ 274,507

Software Development Costs (Fut

Software Development Costs (Future Amortization of Software) (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Total	$ 741,183	$ 776,924
Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2022	182,021
2023	92,161
2024	325
Total	$ 274,507

Operating Lease Assets (Narrati

Operating Lease Assets (Narrative) (Details)	Feb. 01, 2021USD ($)	Mar. 31, 2022USD ($)ft²	Mar. 31, 2021USD ($)	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease liability		$ 1,365,431
Fixed Assets Contributed by Lessor			$ 110,000
Lease Ending January 2027 [Member]
Lessee, Lease, Description [Line Items]
Area of office | ft²		8,898
Lease abatement percentage		50.00%		50.00%
Deposit assets	$ 110,000
Operating lease liability		$ 1,365,431
Fixed Assets Contributed by Lessor	$ 110,000
Lease Ending January 2027 [Member] | Arizona [Member]
Lessee, Lease, Description [Line Items]
Operating lease liability		1,362,079
Minimum [Member] | Lease Ending January 2027 [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense		25,953
Maximum [Member] | Lease Ending January 2027 [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense		$ 28,733

Operating Lease Assets (Additio

Operating Lease Assets (Additional Details Related to Leases on Balance Sheet) (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Operating Lease Assets [Abstract]
Noncurrent operating lease assets	$ 1,132,317	$ 1,187,537
Total lease assets	1,132,317
Operating lease liabilities	237,761	229,240
Noncurrent operating lease liabilities	1,127,670	$ 1,188,589
Total lease liabilities	$ 1,365,431

Operating Lease Assets (Schedul

Operating Lease Assets (Schedule of Minimum Lease Payments Including Weighted-Average Remaining Lease Term and Discount Rates) (Details)	Mar. 31, 2022USD ($)
Operating Lease
2022	$ 241,949
2023	324,221
2024	330,894
2025	337,568
2026	344,241
Thereafter	28,733
Total future lease payments	1,607,606
Less: imputed interest	(242,175)
Total	$ 1,365,431
Weighted Average Remaining Lease Term (years) Operating leases	5 years 7 months 6 days
Weighted Average Discount Rate Operating leases	6.75%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Narrative) (Details)

Feb. 09, 2022$ / sharesshares

Nov. 19, 2021USD ($)

Jul. 01, 2021USD ($)shares

Jun. 30, 2021USD ($)$ / sharesshares

Dec. 31, 2020USD ($)

Nov. 18, 2020USD ($)item

Feb. 28, 2018USD ($)

Mar. 31, 2022USD ($)itemshares

Mar. 31, 2022CAD ($)item

Mar. 31, 2021USD ($)shares

Dec. 31, 2021USD ($)shares

Aug. 11, 2021USD ($)

Apr. 22, 2020CAD ($)

Feb. 26, 2020USD ($)

Debt Instrument [Line Items]

Warrants to purchase common stock | shares

3,188,190

Warrant exercise price | $ / shares

$ 1.50

Warrant exercisable period, after issuance of financing

3 years

Fair value of warrants

$ 5,285

Commissions paid

$ 0

Interest expense

$ 159,827

$ 32,516

Warrant Issuance Four [Member]

Debt Instrument [Line Items]

Warrants to purchase common stock | shares

227,994

Warrant exercise price | $ / shares

$ 1.67

Warrant exercisable period, after issuance of financing

36 months

Fair value of warrants

$ 119,103

Warrant Issuance Four, Volume Weighted Average Price [Member]

Debt Instrument [Line Items]

Warrants to purchase common stock | shares

108,234

ACOA Note [Member]

Debt Instrument [Line Items]

Maturity date

Feb. 1, 2024

Feb. 1, 2024

Repayment of promissory note

$ 6,554

ACOA Note [Member] | November 6, 2017 to October 31, 2019 [Member]

Debt Instrument [Line Items]

Principal payment

$ 3,000

ACOA Note [Member] | November 1, 2019 to July 31, 2021 [Member]

Debt Instrument [Line Items]

Principal payment

3,500

ACOA Note [Member] | August 1, 2021 to July 31, 2022 [Member]

Debt Instrument [Line Items]

Principal payment

4,000

ACOA Note [Member] | August 1, 2022 to February 1, 2024 [Member]

Debt Instrument [Line Items]

Principal payment

4,500

ACOA Note [Member] | Remaining Term [Member]

Debt Instrument [Line Items]

Principal payment

$ 2,215

TD Bank [Member]

Debt Instrument [Line Items]

Initial maturity date

Dec. 31, 2022

Dec. 31, 2022

Maturity date

Dec. 31, 2022

Dec. 31, 2022

Debt instrument principal amount

$ 40,000

Debt instrument interest rate

0.00%

Percent of loan forgiven

25.00%

25.00%

Percent of loan repaid requirement for forgiveness

75.00%

75.00%

TD Bank [Member] | April 22, 2020 to January 1, 2023 [Member]

Debt Instrument [Line Items]

Principal payment

$ 0

Credit Agreement [Member]

Debt Instrument [Line Items]

Repayment of line of credit

$ 200,000

Certain Investors, Officers and Directors [Member] | Unsecured Notes Issued July 1, 2021 [Member]

Debt Instrument [Line Items]

Maturity date

Jul. 1, 2023

Jul. 1, 2023

Debt instrument principal amount

$ 271,875

Debt instrument interest rate

15.00%

Prepayment penalty

2.00%

2.00%

Warrants to purchase common stock | shares

20,339

600,570

Warrants issued | shares

33,017

Fair value of warrants

$ 6,201

$ 286,296

Commissions paid

$ 0

Certain Related Party [Member] | Unsecured Notes Issued February 26 And November 18, 2020 [Member]

Debt Instrument [Line Items]

Debt instrument conversion amount

$ 1,200,000

Debt instrument conversion, accrued interest

192,208

Gain (loss) on extinguishment of debt

(668,260)

Note payable

580,000

Accrued interest

$ 42,492

Certain Related Party [Member] | Unsecured Note Issued February 26, 2020 [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 200,000

Debt instrument term

2 years

2 years

Debt instrument interest rate

15.00%

Prepayment penalty

2.00%

2.00%

Certain Related Party [Member] | Unsecured Notes Issued November 18, 2020 [Member]

Debt Instrument [Line Items]

Number of notes issued | item

2

Debt instrument principal amount

$ 500,000

Debt instrument term

2 years

2 years

Debt instrument interest rate

15.00%

Prepayment penalty

2.00%

2.00%

Director [Member] | Credit Agreement [Member]

Debt Instrument [Line Items]

Maturity date

Jun. 30, 2024

Jun. 30, 2024

Debt instrument interest rate

15.00%

Accrued interest

149,040

Maximum borrowing capacity

$ 3,500,000

Repayment of line of credit

$ 200,000

Amount outstanding

3,478,125

3,478,125

Amount drawn from facility

3,206,250

3,206,250

Increase from conversion of note payable

$ 271,875

$ 271,875

Number of monthly installments | item

24

24

Warrants to purchase common stock | shares

600,570

Warrant exercise price | $ / shares

$ 1.67

Warrant exercisable period, after issuance of financing

36 months

Credit facility fee, numerator

20.00%

Credit facility fee, denominator measurement period

30 days

Warrant vesting period

3 years

Fair value of warrants issued

$ 262,758

Notes Payable and Interest Ex_4

Notes Payable and Interest Expense (Schedule of Notes Payable) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Total Debt	$ 3,439,617	$ 3,426,380
Less current portion	1,520,744	888,583
Long-term debt, net of current portion	$ 1,918,873	2,537,797
ACOA Note [Member]
Debt Instrument [Line Items]
Maturity	Feb. 1, 2024
Total Debt	$ 71,389	76,642
TD Bank [Member]
Debt Instrument [Line Items]
Maturity	Dec. 31, 2022
Interest Rate	0.00%
Total Debt	$ 31,982	31,496
Related Party Note [Member]
Debt Instrument [Line Items]
Interest Rate	15.00%
Total Debt	$ 3,336,246	$ 3,318,242

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details)	Mar. 29, 2022USD ($)employeeitem$ / sharesshares	Feb. 09, 2022USD ($)item$ / sharesshares	Dec. 15, 2021USD ($)item$ / sharesshares	Aug. 11, 2021USD ($)employee$ / sharesshares	Jun. 30, 2021USD ($)$ / sharesshares	May 12, 2021USD ($)employee$ / sharesshares	May 02, 2021USD ($)employee$ / sharesshares	Mar. 26, 2021USD ($)employee$ / sharesshares	Mar. 02, 2020USD ($)employee$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Mar. 31, 2022USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)shares	Sep. 30, 2021$ / sharesshares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares		3,188,190
Warrant exercise price | $ / shares		$ 1.50
Warrant exercisable period, after issuance of financing		3 years
Fair value of warrants				$ 5,285
Equity payable											$ 100,862	$ 100,862	$ 100,862
Number of employees, awards granted | employee	1			1			1	5
Options granted | shares	150,000			5,000			20,000	67,500			150,000		637,500
Weighted average grant date fair value of options granted | $ / shares				$ 1.75			$ 1.48	$ 1.80			$ 0.54
Exercise price | $ / shares	$ 0.8289	$ 0.80
Volatility rate	72.33%			73.29%			74.79%	73.97%			72.33%	73.97%
Call option value, price per share | $ / shares	$ 0.54			$ 1.12			$ 0.93	$ 1.16
Call option value	$ 81,035			$ 5,606			$ 18,628	$ 78,492
Units issued | shares											78,420		654,663
Contractual terms (period)											3 years
Stock-based compensation expense		$ 382,048
Number of warrant holders that exercised warrants | item		17
Shares issued for conversion of warrants | shares		3,188,190
Issuance of common stock for warrant											$ 2,550,553
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | $ / shares											$ 0.83
Twelve Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate	25.00%			25.00%			25.00%	25.00%
Thirty-Six Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting period	36 months			36 months			36 months	36 months
Board of Directors [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Value of units											$ 65,002
Warrant Issuance [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Stock-based compensation expense											$ 382,048
Warrant Issuance One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares									234,500
Warrant exercise price | $ / shares									$ 1
Number of warrant holders that exercised warrants | employee									1
Warrant Issuance Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares										2,666,459
Warrant exercise price | $ / shares										$ 1.25
Warrants outstanding | shares										2,691,459
Warrant Issuance Three [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares										2,666,459
Warrant exercise price | $ / shares										$ 2				$ 2.06
Warrants outstanding | shares														2,666,459
Warrant Issuance Four [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares					227,994
Warrant exercise price | $ / shares					$ 1.67
Warrants outstanding | shares														238,066
Warrant exercisable period, after issuance of financing					36 months
Fair value of warrants					$ 119,103
Warrant Issuance Four, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares											119,760
Warrant Issuance Four, Volume Weighted Average Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares											108,234
Warrant Issuance Five [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants to purchase common stock | shares				10,072
Warrant exercisable period, after issuance of financing				36 months
Restricted Stock Units RSU [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unearned compensation											$ 0
Stock-based compensation expense											65,002	$ 68,696
Restricted Stock Units RSU [Member] | Board of Directors [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of employees, awards granted	4		4	4		4		4
Units issued | shares	78,420		42,484	37,143		38,924		36,112
Value of units	$ 65,002		$ 65,000	$ 65,000		$ 65,002		$ 65,002
Value of units, per share | $ / shares	$ 0.829		$ 1.53	$ 1.75		$ 1.67		$ 1.80
Board compensation				$ 65,000		$ 65,000		$ 65,000			65,002		$ 260,005
Restricted Stock Units RSU [Member] | Employees [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of employees, awards granted | employee								1
Units issued | shares								1,000,000
Value of units, per share | $ / shares								$ 1.80
Stock-based compensation expense											207,603		$ 187,501
Restricted Stock Units RSU [Member] | Employees [Member] | Forty-Eight Months [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Vesting rate								50.00%
Vesting period								48 months
Restricted Stock Units RSU [Member] | Employees [Member] | Revenue Based Vesting, Tranche One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Revenue threshold for vesting measurement								$ 25,000,000
Vesting rate								15.00%
Vesting period								12 months
Restricted Stock Units RSU [Member] | Employees [Member] | Revenue Based Vesting, Tranche Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Revenue threshold for vesting measurement								$ 50,000,000
Vesting rate								35.00%
Vesting period								12 months
Restricted Stock Units RSU [Member] | Employees [Member] | Change In Control Of Company [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Units issued | shares								300,000
Additional Paid-in Capital [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Issuance of common stock for warrant		$ 2,550,553									$ 2,547,365
Additional Paid-in Capital [Member] | Warrant Issuance One [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Issuance of common stock for warrant									$ 234,500
Additional Paid-in Capital [Member] | Warrant Issuance Two [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Issuance of common stock for warrant										$ 3,333,074

Stockholders' Equity (Stock Opt

Stockholders' Equity (Stock Option Activity) (Details) - $ / shares	Mar. 29, 2022	Aug. 11, 2021	May 02, 2021	Mar. 26, 2021	Mar. 31, 2022	Dec. 31, 2021
Stockholders' Equity [Abstract]
Outstanding at Beginning of Period					6,246,466	6,007,552
Granted	150,000	5,000	20,000	67,500	150,000	637,500
Forfeit/canceled					(65,000)	(272,029)
Expired					(10,250)	(126,557)
Outstanding at End of Period					6,321,216	6,246,466
Exercisable at End of Period					1,763,561
Weighted Average Exercise Price Per Share
Granted					$ 0.83

Stockholders' Equity (Stock Bas

Stockholders' Equity (Stock Based Compensation Expense - Stock Options and Warrants) (Details) - USD ($)	Feb. 09, 2022	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 382,048
Stock Options and Warrants [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		$ 207,603	$ 159,927
Stock Options and Warrants [Member] | General and Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		128,246	84,130
Stock Options and Warrants [Member] | Sales and Marketing [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		12,867	32,745
Stock Options and Warrants [Member] | Engineering, Research and Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense		$ 66,490	$ 43,052

Stockholders' Equity (Valuation

Stockholders' Equity (Valuation Assumptions) (Details)	Mar. 29, 2022	Aug. 11, 2021	May 02, 2021	Mar. 26, 2021	Mar. 31, 2022	Mar. 31, 2021
Stockholders' Equity [Abstract]
Risk-free interest rate					2.47%	1.01%
Expected life (years)					6 years	6 years
Expected dividend yield
Expected volatility	72.33%	73.29%	74.79%	73.97%	72.33%	73.97%

Stockholders' Equity (Restricte

Stockholders' Equity (Restricted Stock Unit Activity) (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period	1,685,141	1,436,728
Awarded, Shares	78,420	654,663
Canceled/forfeited/expired, Shares		(406,250)
Outstanding at End of Period	1,763,561	1,685,141
Vested at end of period	1,763,561

Stockholders' Equity (Stock B_2

Stockholders' Equity (Stock Based Compensation Expense - Restricted Stock) (Details) - USD ($)	Feb. 09, 2022	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 382,048
Restricted Stock Units RSU [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 65,002	$ 68,696
Restricted Stock Units RSU [Member] | General and Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 65,002	65,002
Restricted Stock Units RSU [Member] | Sales and Marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense			$ 3,694

Stockholders' Equity (Summary o

Stockholders' Equity (Summary of Investor Warrant Activity) (Details) - $ / shares	Mar. 29, 2022	Aug. 11, 2021	May 02, 2021	Mar. 26, 2021	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period					6,246,466	6,007,552
Granted	150,000	5,000	20,000	67,500	150,000	637,500
Outstanding at End of Period					6,321,216	6,246,466	6,007,552
Investor Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at Beginning of Period					3,246,690	2,691,459
Granted					3,208,529	580,231
Exercised					(3,188,190)
Canceled/forfeited/expired						(25,000)
Outstanding at End of Period					3,267,029	3,246,690	2,691,459
Outstanding at beginning of period, Weighted Average Exercise Price					$ 2.26	$ 1.99
Outstanding at end of period, Weighted Average Exercise Price					$ 0.83	$ 2.26	$ 1.99
Outstanding, Weighted Average Remaining Contractual Term (Years)					2 years 10 months 6 days	3 years 7 months 2 days	2 years 11 months 8 days

Fair Value Measurements (Financ

Fair Value Measurements (Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - Fair Value, Nonrecurring [Member] - Fair Value Inputs Level 3 [Member] - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Goodwill [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill	$ 411,183	$ 411,183
Intangibles, Net [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Intangibles, net	$ 1,015,690	$ 1,124,720

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2022USD ($)ft²	Jan. 31, 2022
Commitments And Contingencies [Line Items]
Operating lease asset	$ 1,132,317
Operating lease liability	$ 1,365,431
Lease Ending January 2027 [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	8,898
Operating lease asset	$ 1,132,317
Operating lease liability	$ 1,365,431
Lease abatement percentage	50.00%	50.00%
Lease Ending January 2027 [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	28,733
Lease Ending January 2027 [Member] | Arizona [Member]
Commitments And Contingencies [Line Items]
Operating lease asset	1,129,679
Operating lease liability	$ 1,362,079
Lease Ending April 2022 [Member]
Commitments And Contingencies [Line Items]
Area of property | ft²	3,248
Operating lease asset	$ 2,638
Operating lease liability	3,352
Lease Ending April 2022 [Member] | Minimum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	2,665
Lease Ending April 2022 [Member] | Maximum [Member]
Commitments And Contingencies [Line Items]
Monthly rental expense	$ 3,371

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details)	Feb. 09, 2022$ / shares	Nov. 19, 2021USD ($)	Jul. 01, 2021USD ($)shares	Jun. 30, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)	Nov. 18, 2020USD ($)item	Feb. 28, 2018USD ($)	Mar. 31, 2022USD ($)item	Dec. 31, 2021USD ($)	Aug. 11, 2021USD ($)	Feb. 26, 2020USD ($)
Related Party Transaction [Line Items]
Commissions paid							$ 0
Accrued interest								$ 305,364	$ 172,239
Warrant exercisable period, after issuance of financing	3 years
Warrant exercise price | $ / shares	$ 1.50
Fair value of warrants										$ 5,285
Credit Agreement [Member]
Related Party Transaction [Line Items]
Repayment of line of credit		$ 200,000
Warrant Issuance Four [Member]
Related Party Transaction [Line Items]
Warrant exercisable period, after issuance of financing				36 months
Warrant exercise price | $ / shares				$ 1.67
Fair value of warrants				$ 119,103
Certain Investors, Officers and Directors [Member] | Unsecured Notes Issued February 2018 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount							$ 1,080,000
Debt instrument interest rate							15.00%
Prepayment penalty							2.00%
Certain Related Party [Member] | Unsecured Note Issued February 26, 2020 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount											$ 200,000
Debt instrument term								2 years
Debt instrument interest rate								15.00%
Prepayment penalty								2.00%
Certain Related Party [Member] | Unsecured Notes Issued November 18, 2020 [Member]
Related Party Transaction [Line Items]
Number of notes issued | item						2
Debt instrument principal amount						$ 500,000
Debt instrument term								2 years
Debt instrument interest rate								15.00%
Prepayment penalty								2.00%
Certain Related Party [Member] | Unsecured Notes Issued December 31, 2020 [Member]
Related Party Transaction [Line Items]
Debt instrument conversion amount					$ 1,200,000
Debt instrument conversion, accrued interest					192,208
Gain (loss) on extinguishment of debt					$ (668,260)
Director [Member] | Credit Agreement [Member]
Related Party Transaction [Line Items]
Debt instrument interest rate								15.00%
Maturity date								Jun. 30, 2024
Maximum borrowing capacity								$ 3,500,000
Repayment of line of credit		$ 200,000
Amount outstanding								3,478,125	3,478,125
Amount drawn from facility								3,206,250	3,206,250
Increase from conversion of note payable								$ 271,875	271,875
Number of monthly installments | item								24
Accrued interest									$ 149,040
Warrant exercisable period, after issuance of financing				36 months
Warrant exercise price | $ / shares				$ 1.67
Warrant vesting period				3 years
Credit facility fee, numerator				20.00%
Credit facility fee, denominator measurement period				30 days
Director [Member] | Unsecured Notes Issued July 1, 2021 [Member]
Related Party Transaction [Line Items]
Debt instrument principal amount			$ 271,875
Debt instrument interest rate								15.00%
Prepayment penalty								2.00%
Maturity date								Jul. 1, 2023
Commissions paid			$ 0
Warrants issued | shares			33,017